Contact
Header_1077x260px_About_Profil.jpg

Happy new year 2019

2018 is over -  and the Profil blog has seen many interesting articles through the last months. We have posted about conferences, webinars and scientific topics for clinical diabetes researchers. 

We are happy to see that many readers are interested in our blog posts. Our most popular blogs deal with the error grid analysis, improvements of insulin injections and diabetic and hepatic encephalopathyWe are very pleased that the Profil blog has found so many readers again last year and we will continue to bring the most interesting topics to you also in 2019.

Read More

Topics: About Profil

Posted by Svenya Meister on Jan 3, 2019 5:23:00 PM
svenya-meister

"Profil World" - The clinical diabetes research newsletter - October 2018

Dear all,

Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity.

Read More

Topics: About Profil

Posted by Dr. Lars Bochmann on Oct 11, 2018 5:21:00 PM
dr-lars-bochmann

Profil at EASD Annual Meeting 2018

About EASD Annual Meeting

Profil will be present at EASD Annual Meeting with numerous posters as well as some presentations. Of course we look forward to this exciting event very much. 

We are proud that Profil will be a sponsor of Solvable Problems in Diabetes at EASD Annual Meeting 2018 in Berlin. The event will take place on Thursday, October 4, 2018, from 7:00-9:00 pm during the 2018 annual meeting for the European Association of the Study of Diabetes (EASD). Learn more about the event here

To meet Profil at the EASD Annual Meeting please fill out the request form at our website.

Read More

Topics: About Profil

Posted by Dr. Lars Bochmann on Sep 14, 2018 12:21:35 PM
dr-lars-bochmann

Free webinar on EU-funded R&D partnerships in healthy living and active ageing

Profil continues the successful series of scientific webinars. On September 12th we will air our webinar on "EU-funded R&D partnerships in healthy living and active ageing". The session is presented by Prof. Dr. Freimut Schliess, Director Science & Innovation at Profil and Jakob Haardt, Research & Innovation Manager at Eurice. 

Read More

Topics: About Profil

Posted by Svenya Meister on Aug 14, 2018 5:18:00 PM
svenya-meister

"Profil World" - The clinical diabetes research newsletter - July 2018

Dear all,

Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity.

Read More

Topics: About Profil

Posted by Dr. Lars Bochmann on Jul 18, 2018 5:21:00 PM
dr-lars-bochmann

D4kids: Profil joined a new pan-European Artificial Pancreas initiative

Profil is part of the new Diabeloop for children (D4kids) pan-European consortium for functionally enhancing an Artificial Pancreas (AP) system to better serve the needs and requirements of children with type 1 diabetes (T1D) and their families.

Based on a co-creative approach and clinical evidence D4kids will adapt the AP system with the ambition to

  • ameliorate the long-term trajectories of T1D
  • enhance the quality of life of children and their families
  • boost pediatric care
  • improve the sustainability of European healthcare Systems
Read More

Topics: Treating Diabetes, About Profil

Posted by Prof. Dr. Freimut Schliess on May 2, 2018 4:53:00 PM
prof-dr-freimut-schliess

Profil is committed to the highest quality - including the training of our staff

Profil conducts world-leading clinical research and sets the highest standards with respect to quality of study design, results, and employees. Because of the special requirements that our employees have to fulfill, we make sure that best-in-class training is guaranteed. One example are our study nurses, who take on important tasks in everyday research. Among other things, they coordinate processes, collect and document study-relevant data.

But although the Study Nurses are indispensable, they do not have a protected job title. Moreover a uniform regulation for the training is missing. That is why we decided together with the Chamber of Commerce (IHK) to establish a certificate course. In this form and extent we are the only provider in Germany. Typical topics that are covered by the IHK include work organization and self-management. Our experts provide insights into pharmacology or the in-house quality management system.

This process of training our employees guarantees that Profil can recruit promising experts in their field and further educate them to help our sponsors find answers for diabetes. 

Read More

Topics: About Profil

Posted by Sara Schwarzer on Apr 24, 2018 5:17:00 PM
sara-schwarzer

"Profil World" - The clinical diabetes research newsletter - March 2018

Dear all,

Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity.

Read More

Topics: About Profil

Posted by Dr. Lars Bochmann on Mar 23, 2018 2:09:00 PM
dr-lars-bochmann

Dr. Tim Heise about Profil's 2017 Science Report

Dear all,

I am very proud to present the Profil Science Report 2017. As in the last years, our Science Report impressively documents the sound scientific expertise standing of Profil.

With 49 scientific publications (cumulated impact factor of > 300) and 70 scientific presentations at international meetings, our publication record at Profil can easily compete with that of many academic institutions. By being part of transdisciplinary knowledge and innovation communities such as CBmed and EIT Health we contribute to shaping cutting-edge innovations in method development, diabetes technology, and healthcare provision.

Read More

Topics: About Profil

Posted by Dr. Tim Heise on Feb 2, 2018 9:14:26 AM
dr-tim-heise

Professor Hans de Vries joins Profil

Profil announced the appointment of Professor Hans de Vries as Senior Medical Scientist. “Dr. de Vries is a world-leading expert in diabetes with a high international reputation for his scientific contributions, in particular in the fields of treatment of type 1 and type 2 diabetes as well as in the development of an artificial pancreas,” said Dr. Tim Heise, Lead Scientist and Chairman of the Board of Directors at Profil. “All of us at Profil are very proud that such a renowned scientist joins our team. Dr. de Vries will help us to further expand and improve our scientific activities which set ourselves apart from other contract research organisations.”

Read More

Topics: About Profil

Posted by Dr. Lars Bochmann on Dec 29, 2017 11:52:21 AM
dr-lars-bochmann

Subscribe to our monthly blog updates

New Call-to-action

Subscribe to Email Updates

Our most popular Posts